XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 915 $ 997
Short-term investments 6 11
Accounts receivable, net 1,312 1,093
Inventories 1,225 1,187
Prepaid expenses and assets held for sale 58 67
Total current assets 3,516 3,355
Property, plant and equipment, net of accumulated depreciation of $3,679 and $3,476 2,435 2,264
Intangible assets, net of accumulated amortization of $346 and $324 1,273 1,264
Other non-current assets 609 561
Total assets 7,833 7,444
Current liabilities:    
Short-term borrowings 57 44
Accounts payable 652 604
Accrued liabilities and liabilities held for sale 569 633
Total current liabilities 1,278 1,281
Long-term debt 1,741 1,787
Other non-current liabilities 490 486
Total liabilities 3,509 3,554
Share-based payments subject to redemption 58 60
Redeemable non-controlling interests 7 7
Ingredion stockholders’ equity:    
Preferred stock — authorized 25.0 shares — $0.01 par value, none issued 0 0
Common stock — authorized 200.0 shares — $0.01 par value, 77.8 shares issued at September 30, 2025 and December 31, 2024 1 1
Additional paid-in capital 1,156 1,152
Less: Treasury stock (common stock: 14.1 and 13.3 shares at September 30, 2025 and December 31, 2024) at cost (1,466) (1,355)
Accumulated other comprehensive loss (950) (1,086)
Retained earnings 5,497 5,092
Total Ingredion stockholders’ equity 4,238 3,804
Non-redeemable non-controlling interests 21 19
Total stockholders’ equity 4,259 3,823
Total liabilities and stockholders’ equity $ 7,833 $ 7,444